Table of Content

1 Report Overview
1.1 Global Biopharmaceuticals Excipients Market Overview
1.2 Segmentation
1.3 Market Drivers, Restraints and Opportunities
1.4 Why You Should Read This Report
1.5 How This Report Delivers
1.6 Key Questions Answered by This Analytical Report Include:
1.7 Methodology
1.7.1 Secondary Research
1.7.2 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQ)

2 Introduction to the Biopharmaceuticals Excipients Market
2.1 Biopharmaceutical Excipients Product
2.1.1 Solubilizers & Surfactants/Emulsifiers
2.1.2 Polyols
2.1.3 Carbohydrates
2.1.4 Specialty Biopharmaceutical Excipients/Others

3 Global Biopharmaceuticals Excipients Market Analysis
3.1 PEST Analysis of the Biopharmaceuticals Excipients Market
3.2 Market Outlook
3.3 Drivers & Restraints
3.3.1 Growth in the biopharmaceutical industry
3.3.2 Increasing burden of chronic disease
3.4 Market Opportunity
3.4.1 Advances in bioprocessing and biopharmaceutical industry, such as the rise in outsourcing trend
3.5 Market Challenges
3.5.1 Regulatory environment
3.5.2 Pricing of medicines
3.6 Dominant Region/Country
3.7 Biopharmaceuticals Excipients Overall Operating Scenario
3.8 Overall Growth Rate, Globally
3.9 SWOT Analysis
3.9.1 Strengths
3.9.2 Weaknesses
3.9.3 Opportunities
3.9.4 Threats

4 Global Biopharmaceuticals Excipients Market 2020-2030
4.1 Global Biopharmaceutical Excipients Product Market 2020-2030
4.1.1 Global Solubilizers & Surfactants/Emulsifiers Market 2020-2030
4.1.2 Global Polyols Market 2020-2030
4.1.3 Global Carbohydrates Market 2020-2030
4.1.4 Global Specialty Biopharmaceutical Excipients/Others Market 2020-2030

5 The Leading National Biopharmaceuticals Excipients Market Forecasts 2020-2030
5.1 Regional Overview
5.1.1 North America
5.1.2 Europe
5.1.3 Asia-Pacific
5.1.4 Middle East & Africa
5.1.5 Rest of the World
5.1.6 Leading Countries/ Regions by Biopharmaceuticals Excipients Market
5.2 Canada Biopharmaceuticals Excipients Market 2020-2030
5.2.1 Canada Biopharmaceuticals Excipients Submarket, By Product Forecast 2020-2030
5.2.2 Canada Biopharmaceuticals Excipients Market Analysis
5.3 U.S. Biopharmaceuticals Excipients Market 2020-2030
5.3.1 U.S. Biopharmaceuticals Excipients Submarket, By Product Forecast 2020-2030
5.3.2 U.S. Biopharmaceuticals Excipients Market Analysis
5.4 Germany Biopharmaceuticals Excipients Market 2020-2030
5.4.1 Germany Biopharmaceuticals Excipients Submarket, By Product Forecast 2020-2030
5.4.2 Germany Biopharmaceuticals Excipients Market Analysis
5.5 France Biopharmaceuticals Excipients Market 2020-2030
5.5.1 France Biopharmaceuticals Excipients Submarket, By Product Forecast 2020-2030
5.5.2 France Biopharmaceuticals Excipients Market Analysis
5.6 U.K. Biopharmaceuticals Excipients Market 2020-2030
5.6.1 U.K. Biopharmaceuticals Excipients Submarket, By Product Forecast 2020-2030
5.6.2 U.K. Biopharmaceuticals Excipients Market Analysis
5.7 Italy Biopharmaceuticals Excipients Market 2020-2030
5.7.1 Italy Biopharmaceuticals Excipients Submarket, By Solubilizers & Surfactants/Emulsifiers Type Forecast 2020-2030
5.7.2 Italy Biopharmaceuticals Excipients Market Analysis
5.8 Spain Biopharmaceuticals Excipients Market 2020-2030
5.8.1 Spain Biopharmaceuticals Excipients Submarket, By Product Forecast 2020-2030
5.8.2 Spain Biopharmaceuticals Excipients Market Analysis
5.9 China Biopharmaceuticals Excipients Market 2020-2030
5.9.1 China Biopharmaceuticals Excipients Submarket, By Product Forecast 2020-2030
5.9.2 China Biopharmaceuticals Excipients Market Analysis
5.10 Australia Biopharmaceuticals Excipients Market 2020-2030
5.10.1 Australia Biopharmaceuticals Excipients Submarket, By Solubilizers & Surfactants/Emulsifiers Type Forecast 2020-2030
5.10.2 Australia Biopharmaceuticals Excipients Market Analysis
5.11 India Biopharmaceuticals Excipients Market 2020-2030
5.11.1 India Biopharmaceuticals Excipients Submarket, By Product Forecast 2020-2030
5.11.2 India Biopharmaceuticals Excipients Market Analysis
5.12 Indonesia Biopharmaceuticals Excipients Market 2020-2030
5.12.1 Indonesia Biopharmaceuticals Excipients Submarket, By Product Forecast 2020-2030
5.12.2 Indonesia Biopharmaceuticals Excipients Market Analysis
5.13 South Korea Biopharmaceuticals Excipients Market 2020-2030
5.13.1 South Korea Biopharmaceuticals Excipients Submarket, By Solubilizers & Surfactants/Emulsifiers Type Forecast 2020-2030
5.13.2 South Korea Biopharmaceuticals Excipients Market Analysis
5.14 Rest of Asia Biopharmaceuticals Excipients Market 2020-2030
5.14.1 Rest of Asia Biopharmaceuticals Excipients Submarket, By Product Forecast 2020-2030
5.14.2 Rest of Asia Biopharmaceuticals Excipients Market Analysis
5.15 Middle East Biopharmaceuticals Excipients Market 2020-2030
5.15.1 Middle East Biopharmaceuticals Excipients Submarket, By Product Forecast 2020-2030
5.15.2 Middle East Biopharmaceuticals Excipients Market Analysis
5.16 Africa Biopharmaceuticals Excipients Market 2020-2030
5.16.1 Africa Biopharmaceuticals Excipients Submarket, By Product Forecast 2020-2030
5.16.2 Africa Biopharmaceuticals Excipients Market Analysis
5.17 Rest of the World Biopharmaceuticals Excipients Market 2020-2030
5.17.1 Rest of the World Biopharmaceuticals Excipients Submarket, By Product Forecast 2020-2030
5.17.2 Rest of the World Biopharmaceuticals Excipients Market Analysis

6 The Leading Companies in the Biopharmaceuticals Excipients Market
6.1 Abitec Corp.
6.1.1 Abitec Corp. Overview
6.1.2 Abitec Corp. Product Portfolio
6.1.3 Abitec Corp. SWOT Analysis
6.1.4 Abitec Corp. Key Development
6.2 Signet Chemical Corporation Pvt. Ltd.
6.2.1 Signet Chemical Corporation Overview
6.2.2 Signet Chemical Corporation SWOT Analysis
6.2.3 Signet Chemical Corporation Recent Development
6.3 Roquette Freres SA
6.3.1 Roquette Freres SA Overview
6.3.2 Roquette Freres SA SWOT Analysis
6.3.3 Roquette Freres SA Recent Development
6.4 Sigachi Industries Pvt. Ltd.
6.4.1 Sigachi Industries Overview
6.4.2 Sigachi Industries Product Portfolio
6.4.3 Sigachi Industries SWOT Analysis
6.5 Meggle AG
6.5.1 Meggle Overview
6.5.2 Meggle Product Offering
6.5.3 Meggle AG SWOT Analysis
6.5.4 Meggle Recent Development
6.6 Colorcon, Inc.
6.6.1 Colorcon Overview
6.6.2 Colorcon Product Portfolio
6.6.3 Colorcon SWOT Analysis
6.6.4 Colorcon Recent Development
6.7 DMV-Fonterra Excipients GmbH & Co. KG
6.7.1 DMV-Fonterra Excipients Overview
6.7.2 DMV-Fonterra Excipients Product Offerings
6.7.3 DMV-Fonterra Excipients SWOT Analysis
6.7.4 DMV-Fonterra Excipients Recent Development
6.8 Clariant AG
6.8.1 Clariant Overview
6.8.2 Clariant Product Offering
6.8.3 Clariant SWOT Analysis
6.8.4 Clariant Recent Development
6.9 SPI Pharma Inc.
6.9.1 SPI Overview
6.9.2 SPI Product Offerings
6.9.3 SPI SWOT Analysis
6.9.4 SPI Recent Development
6.10 Pharmonix Biological Pvt. Ltd.
6.10.1 Pharmonix Overview
6.10.2 Pharmonix Product Offering
6.10.3 Pharmonix SWOT Analysis

7 Conclusions and Recommendations
7.1 Global Biopharmaceuticals Excipients Market Outlook
7.2 Recommendations

8 Glossary

List of Tables
Table 2.1 Companies Providing Solubilizers and Surfactants Products, Features and Applications
Tabel 3.1 Licensed Biological Products, 2019
Table 4.1 Global Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
Table 4.2 Global Biopharmaceuticals Excipients Market Forecast by Solubilizers & Surfactants/Emulsifiers 2020-2030 (US$m, AGR %, Cumulative)
Table 4.3 Global Biopharmaceuticals Excipients Market Forecast by Polyols 2020-2030 (US$m, AGR %, Cumulative)
Table 4.4 Global Biopharmaceuticals Excipients Market Forecast by Carbohydrates 2020-2030 (US$m, AGR %, Cumulative)
Table 4.5 Global Biopharmaceuticals Excipients Market Forecast by Specialty Biopharmaceutical Excipients 2020-2030 (US$m, AGR %, Cumulative)
Table 5.1 North America Biopharmaceutical Excipient Markets Forecast by Country 2020-2030 (US$m, AGR %, Cumulative)
Table 5.2 Europe Biopharmaceutical Excipient Markets Forecast by Country 2020-2030 (US$m, AGR %, Cumulative)
Table 5.3 Asia-Pacific Biopharmaceutical Excipient Markets Forecast by Country 2020-2030 (US$m, AGR %, Cumulative)
Table 5.4 Rest of World Biopharmaceutical Excipient Markets Forecast by Country 2020-2030 (US$m, AGR %, Cumulative)
Table 5.5 Canada Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
Table 5.6 US Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
Table 5.7 Germany Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
Table 5.8 France Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
Table 5.9 UK Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
Table 5.10 Italy Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
Table 5.11 Spain Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
Table 5.12 China Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
Table 5.13 Australia Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
Table 5.14 India Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
Table 5.15 Indonesia Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
Table 5.16 South Korea Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
Table 5.17 Rest of Asia Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
Table 5.18 Middle East Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
Table 5.19 Africa Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
Table 5.20 Rest of the World Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
Table 6.1 ABITEC CORP. 2020 (CEO, Company Sales (US$ m), Sales in the market (US$ m), Business segment in the market, HQ, No. of Employees, Website)
Table 6.2 Abitec Corp. Product Portfolio, 2020
Table 6.3 Signet Chemical Corporation Pvt. Ltd. 2020 (CEO, Company Sales (US$ m), Sales in the market (US$ m), Business segment in the market, HQ, No. of Employees, Website)
Table 6.4 Roquette Freres SA 2020 (CEO, Company Sales (US$ m), Sales in the market (US$ m), Business segment in the market, HQ, No. of Employees, Website)
Table 6.5 Roquette Freres SA Product Portfolio 2020
Table 6.6 Sigachi Industries Pvt. Ltd. 2020 (CEO, Company Sales (US$ m), Sales in the market (US$ m), Business segment in the market, HQ, No. of Employees, Website)
Table 6.7 Sigachi Industries Pvt. Ltd. Product Portfolio 2020
Table 6.8 Meggle AG 2020 (CEO, Company Sales (US$ m), Sales in the market (US$ m), Business segment in the market, HQ, No. of Employees, Website)
Table 6.9 Meggle AG Product Portfolio 2020
Table 6.10 Colorcon, Inc. 2020 (CEO, Company Sales (US$ m), Sales in the market (US$ m), Business segment in the market, HQ, No. of Employees, Website)
Table 6.11 Colorcon, Inc. Product Portfolio 2020
Table 6.12 DMV-Fonterra Excipients GmbH & Co. KG 2020 (CEO, Company Sales (US$ m), Sales in the market (US$ m), Business segment in the market, HQ, No. of Employees, Website)
Table 6.13 DMV-Fonterra Excipients GmbH & Co. KG Product Portfolio 2020
Table 6.14 Clariant AG 2020 (CEO, Company Sales (US$ m), Sales in the market (US$ m), Business segment in the market, HQ, No. of Employees, Website)
Table 6.15 Clariant AG Product Portfolio 2020
Table 6.16 SPI Pharma Inc. 2020 (CEO, Company Sales (US$ m), Sales in the market (US$ m), Business segment in the market, HQ, No. of Employees, Website)
Table 6.17 SPI Product Portfolio 2020
Table 6.18 Pharmonix Biological Pvt. Ltd. 2020 (CEO, Company Sales (US$ m), Sales in the market (US$ m), Business segment in the market, HQ, No. of Employees, Website)
Table 6.19 Pharmonix Product Portfolio 2020

List of Figures


Figure 1.1 Global Biopharmaceutical Excipient Market Forecast 2020-2030 (US$ m, AGR %)
Figure 1.2 Global Biopharmaceutical Excipients Market Segmentation
Figure 3.1 US Healthcare Expenditure, 1970-2017 (Billion)
Figure 3.2 Benefits provided by business collaborations
Figure 4.1 Global Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
Figure 4.2 Global Biopharmaceuticals Excipients Market Forecast by Solubilizers & Surfactants/Emulsifiers 2020-2030 (US$m, Global AGR %)
Figure 4.3 Global Biopharmaceuticals Excipients Market Forecast by Triglycerides 2020-2030 (US$m, Global AGR %)
Figure 4.4 Global Biopharmaceuticals Excipients Market Forecast by Esters 2020-2030 (US$m, Global AGR %)
Figure 4.5 Global Biopharmaceuticals Excipients Market Forecast by Others 2020-2030 (US$m, Global AGR %)
Figure 4.6 Global Biopharmaceuticals Excipients Market Forecast by Polyols 2020-2030 (US$m, Global AGR %)
Figure 4.7 Global Biopharmaceuticals Excipients Market Forecast by Mannitol 2020-2030 (US$m, Global AGR %)
Figure 4.8 Global Biopharmaceuticals Excipients Market Forecast by Sorbitol 2020-2030 (US$m, Global AGR %)
Figure 4.9 Global Biopharmaceuticals Excipients Market Forecast by Others 2020-2030 (US$m, Global AGR %)
Figure 4.10 Global Biopharmaceuticals Excipients Market Forecast by Carbohydrates 2020-2030 (US$m, Global AGR %)
Figure 4.11 Global Biopharmaceuticals Excipients Market Forecast by Sucrose 2020-2030 (US$m, Global AGR %)
Figure 4.12 Global Biopharmaceuticals Excipients Market Forecast by Dextrose 2020-2030 (US$m, Global AGR %)
Figure 4.13 Global Biopharmaceuticals Excipients Market Forecast by Starch 2020-2030 (US$m, Global AGR %)
Figure 4.14 Global Biopharmaceuticals Excipients Market Forecast by Others 2020-2030 (US$m, Global AGR %)
Figure 4.15 Global Biopharmaceuticals Excipients Market Forecast by Specialty Biopharmaceutical Excipients 2020-2030 (US$m, Global AGR %)
Figure 5.1 North America Biopharmaceutical Excipient Markets Forecast by Country 2020-2030 (US$m, AGR %, Cumulative)
Figure 5.2 Europe Biopharmaceutical Excipient Markets Forecast by Country 2020-2030 (US$m, AGR %, Cumulative)
Figure 5.3 Asia Pacific Biopharmaceutical Excipient Markets Forecast by Country 2020-2030 (US$m, AGR %, Cumulative)
Figure 5.4 Rest of World Biopharmaceutical Excipient Markets Forecast by Country 2020-2030 (US$m, AGR %, Cumulative)
Figure 5.5 Canada Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
Figure 5.6 US Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
Figure 5.7 Germany Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
Figure 5.8 France Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
Figure 5.9 UK Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
Figure 5.10 Italy Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
Figure 5.11 Spain Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
Figure 5.12 China Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
Figure 5.13 Australia Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
Figure 5.14 India Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
Figure 5.15 Indonesia Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
Figure 5.16 South Korea Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
Figure 5.17 Rest of Asia Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
Figure 5.18 Middle East Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
Figure 5.19 Africa Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
Figure 5.20 Rest of the World Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)